FREMONT, Calif., Jan. 7, 2011 /PRNewswire/ -- WaferGen Biosystems, Inc. (OTC Bulletin Board: WGBS), a leading developer of state-of-the-art genomic analysis systems, today announced that it will present an overview of the company at the 4th Annual OneMedForum Business Development and Investment Conference for emerging healthcare and life science companies held concurrently with the JP Morgan Healthcare Conference in San Francisco, January 11-13, 2011.
The presentation will occur at the Sir Francis Drake Hotel in San Francisco on Wednesday, January 12, 2011 at 2:30 p.m. Pacific time. It will be Webcast live and may be accessed at www.wafergen.com; and it will be archived for 90 days.
WaferGen Biosystems, Inc. is a leader in the development, manufacture and sale of state-of-the-art systems for genomic analysis for the life science and pharmaceutical industries. The company currently offers the breakthrough SmartChip Real-Time PCR system, the next-generation Real-Time PCR system for discovery and validation of biomarkers, or gene expression patterns, on a single platform. The company believes that the SmartChip system is ideal for researchers seeking to confirm discoveries made with the growing use of next-generation sequencing. In addition, the high throughput capabilities of the SmartChip system enable scientists to extend their research across large panels of genes, and hundreds of samples, at a reasonable cost.
In addition, the company offers an innovative fee-based service for gene-expression profiling using the SmartChip system. For additional information, please see http://www.wafergen.com.
WaferGen | |
510-651-4450 | |
Don Huffman, CFO | |
Joyce Strand | |
SOURCE WaferGen Biosystems, Inc.
